Faculty of Pharmacy and Science of Universitas Muhammadiyah Prof. DR. HAMKA (UHAMKA) in collaboration with Association of Muhammadiyah Pharmacy Higher Education (APTFM) in Indonesia would organize the first International Conference entitled “Muhammadiyah International Conference on Health and Pharmaceutical Development (MICH-PhD)" with the theme of “Current Innovation in Chronic Disease Treatment”. It aims to provide an opportunity for participants to present their research and to expose participants to the development and innovation made in health and various disciplines of pharmacy.

At the conference, participants with pharmaceutical background and other related health backgrounds have a meeting place to expand their knowledge of current development in medical sciences, pharmaceutical biology, pharmaceutical chemistry, community and clinical pharmacy, pharmaceutical technology and other scientific disciplines of pharmacy. This event will be a good opportunity for participants to share their research finding and to establish networks. Providing a precious opportunity, MICH-PhD invites hospital, community, regulatory/enforcement and industrial pharmacists, clinicians, policy makers, academicians, students, pharmaceutical scientists and other researchers, pharmaceutical organizations and all representatives of pharmacy as well as medical sectors to showcase their cutting edge findings and at the same time to be exposed to a useful collection of research and the latest developments. This event is expected to give a significant contribution to the society, particularly in medical and pharmaceutical development.

Plenary Speakers:
dr. Rizki Edmi Edison, PhD
Dr. Arthorn Riewpaiboon
Prof. Dr. B. (Bob) Wilffert
Dr. Nining Sugihartini, M.Si., Apt.
Prof. Patrick Ball
Dr. Hana Morrissey

Authors are requested to submit abstract to the Organizing Committee. The abstract is maximum 200 words and should follow the template which consists of introduction & aims, the method used, result, and conclusion. Accepted abstracts will be required to submit a manuscript of 3000 words. The papers should be written in English and must be between 4 to 6 pages. All papers will undergo a double-blind peer review process.

Papers review process using a double step double-blind system by experts according to their fields. All accepted paper will be processed to publish on Scopus indexed proceeding**) or Pharmaciana (DOAJ indexed journal). Accepted papers were rejected both publishers will be automatically published in the ISSN journal**)

**) on process negotiate